Front Range Pharmaceuticals

Front Range Pharmaceuticals is a clinical-stage biopharmaceutical company based in Wheat Ridge, Colorado, focused on developing standardized botanical drug candidates to modulate the endocannabinoid system (ECS). Operating as the pharmaceutical research and development division of Endourage LLC, the company leverages the FDA's botanical drug development pathway to create safe, pharmacologically active therapeutics for chronic diseases. Its lead candidate, FRP-003 (also known as Formula C™), is an orally administered full-spectrum hemp-CBD formulation combining phytocannabinoids and therapeutic terpenes. In late 2026, the FDA cleared the company's Investigational New Drug (IND) application to initiate a Phase 2 clinical trial of FRP-003 in adults with Long COVID and persistent fatigue.